Skip to main navigation
Skip to search
Skip to main content
Sort by
INIS
carcinomas
100%
patients
88%
cancer
49%
diseases
36%
populations
34%
levels
33%
tumors
30%
plasma
30%
metastases
27%
comparative evaluations
19%
detection
17%
dna
15%
management
14%
methylation
14%
data
13%
doses
13%
monitoring
13%
children
12%
malignancies
12%
variations
12%
screening
11%
therapy
11%
values
11%
steroids
11%
chemotherapy
11%
neoplasms
11%
drugs
11%
netherlands
10%
validation
10%
antigens
10%
Keyphrases
Adrenocortical Carcinoma
82%
Mitotane
55%
Plasma Parameters
26%
Adrenal Tumor
25%
Urinary Steroid Profile
20%
Endocrine Malignancies
20%
Pharmacokinetic Model
17%
Dutch
14%
Disease Stage
13%
Benign Adrenal Tumor
13%
Prognostic Factors
12%
Individualized Dosing
12%
Personalized Dosing
11%
Netherlands
11%
Counseling
11%
Clinical Trials
11%
Working Diagnosis
10%
Heavily Pretreated Patients
10%
Relative Survival
10%
Targeted Immunotherapy
10%
Adrenal Cortex
10%
Adrenolytic Drugs
10%
Abdominal Mass
10%
Patient Care
10%
Hormonal Assay
10%
Disease Stabilization
10%
Proliferation Index
10%
Population Pharmacokinetic Analysis
10%
Objective Response
10%
Targeted Therapy
10%
Medicine and Dentistry
Adrenal Cortex Carcinoma
59%
Diseases
40%
Adrenal Tumor
23%
Overall Survival
20%
Survival Rate
19%
Cancer
17%
Malignant Neoplasm
16%
Urinary System
13%
Neoplasm
12%
Neuroendocrine Tumor
10%
Adrenal Cortex Tumor
10%
Quality of Life
10%
Long Term Survival
10%
Endocrine Disease
10%
Epigenomics
10%
DNA Methylation
10%
Diagnostic Accuracy
10%
Cohort Effect
10%
Prostate Cancer
10%
Adrenal Gland
10%
Positron Emission Tomography-Computed Tomography
10%
Adrenal Cancer
10%
Prostate Specific Membrane Antigen
10%
Urothelial Cancer
10%
Pembrolizumab
10%
Cancer Screening
10%
Early Cancer Detection
10%
Mitotane
9%
Relative Survival
9%
Pediatrics
6%
